Aya Salem, PMP®

• Pre-launch preparations for HS indication including Ad boards, international PCP & others ended by successful launch event.
• Innovative partnerships with governmental & private bodies to enhance patient access to biological treatments in broad spectrum indications. قد التحدي .. قد الأمراض المناعية.
• Tailored Stakeholders' engagement plans with crafted toolkits to enhance customer experience.
• Digital engagements to enhance the pre & post launch readiness by improving the reach to target audience.

• 6-month assignment.
• HS indication launch preparations.

P&L management for HS.

• Creation of HS Communication plan.
• Development of HS promotional materials.

• Medical Advisor with field responsibilities for Breast Cancer.
• Pre-launch readiness plan for Early Breast Cancer.
• Enhanced field readiness within Breast Cancer internal team.

• Responsible for post launch medical excellence in Cosentyx® rheumatological indications “Ankylosing Spondylitis, Non-Radiographic Axial Spondylo-arthritis, Psoriatic Arthritis”.
• Execution of innovative partnerships covering KOLs, KDMs & Payers in the private, institutional & governmental sector.
• Providing digital solutions as part of the OCE engagement plan.
• Leading 2 MSLs dedicated for Rheumatological indications.
• Co-leading the cross functional team in securing Secukinumab position in the governmental reimbursement sector.
• Pre-Launch of two new pediatric indications. “JiPsA: Juvenile Idiopathic Psoriatic Arthritis & ERA: Enthesitis Related Arthritis”.

• Led the team to drive biological therapies performance in Egypt.
• Digital transformation of Psoriasis screening & management protocols in the biggest 5 institutions.
• Worked on key strategic national events to differentiate Psoriasis and build disease gravity.
• Expanded the Derma-Focused HCPs which was globally awarded.
• Led the execution of regional projects with alignment of regional cross-functional colleagues.
• Accelerated the Psoriasis Patient Journey by expanion the reach of activities in 2021 to connect patients & payers in the first of its kind Psoriasis social movement. “قد_التحدي .. قد _الصدفية”.

• Executional Excellence of Cosentyx® Launch in pediatric psoriasis indication in Egypt.
• Bringing national & international expertise together for smooth introduction of the indication.
• Series of events to ensure the understanding of the medical data and aligning on action key points.
• Tactful execution of Pediatric Psoriasis Pre-Launch activities. Identifying pediatric psoriasis patient journey, Mapping key stakeholders & Building a strategic executional plan.
• Led “ First national unified psoriasis patient history sheets ” in collaboration with 17 universities and key accounts which was awarded by the CPO.
• Awarded with the Global Cosentyx ® Medal Award in March 2019 for the execution of the first COE of Psoriasis in Egypt and Medical Launch Excellence of Cosentyx® as the first IL-17 inhibitor, biological therapy in Egypt.

• Launch excellence of Seebri® in 2015.
• Launch excellence of Ultibro® in 2016.
• Best Achiever for the total respiratory portfolio in 2016.